Skip to main content

Advertisement

Table 3 Adverse events in the immunotherapy group

From: Adjuvant cytokine-induced killer cell immunotherapy for hepatocellular carcinoma: a propensity score-matched analysis of real-world data

Adverse event Immunotherapy (n = 59)
Grade 1 or 2 Grade 3 or 4
Overall incidence 16 (27.1%) 0
Anorexia 1 (1.7%) 0
Nausea 1 (1.7%) 0
Vomiting 2 (3.4%) 0
Pruritis 2 (3.4%) 0
Chills 2 (3.4%) 0
Fatigue 4 (6.8%) 0
Pyrexia 3 (5.1%) 0
Productive cough 1 (1.7%) 0